{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:50:32Z","timestamp":1793731832106,"version":"4.6.1"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":173,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["22-20-HOBB"],"award-info":[{"award-number":["22-20-HOBB"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130457"],"award-info":[{"award-number":["P20 GM130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001558","name":"Concern Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA163177"],"award-info":[{"award-number":["T32CA163177"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA044579"],"award-info":[{"award-number":["P30CA044579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5R25GM072643"],"award-info":[{"award-number":["5R25GM072643"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001437","name":"Abney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001437","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is defined by the near universal occurrence of KRAS mutations. The KRASG12R mutation is detected in approximately 15% to 20% of patients with PDAC and rare in other KRAS-mutant cancers. KRASG12R is unable to activate the lipid kinase PIK3CA, suggesting that alternative mechanisms might be employed to activate KRASG12R-independent PI3K signaling in PDAC. In this study, we detected elevated expression of all four PI3K isoforms in PDAC cell lines, with the PIK3CG isoform showing higher overall expression in KRASG12R-mutant PDAC. All four PI3K isoforms contributed to global PI3K signaling, and inhibition of any single isoform was insufficient to limit PDAC proliferation. The combined inhibition of all PI3K isoforms was required to limit proliferation, providing a potential explanation for the limited efficacy of PI3K inhibitors in the clinic. Additionally, PTEN, a negative regulator of PI3K signaling, was inactivated in PDAC by the formation of an intramolecular disulfide, which elevated overall PI3K signaling and reduced the dependency of PI3K signaling on KRAS. Oxidation of PTEN was independent of KRAS mutation status. Finally, nutrient-limiting conditions mimicking the PDAC tumor microenvironment further elevated PTEN oxidation and significantly increased macropinocytosis. Thus, this study uncovered a mechanism that supports elevated PI3K signaling in PDAC, thereby reducing the need for KRAS to directly activate the PI3K pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>PTEN inactivation by intramolecular disulfide bond formation and elevated expression of PI3K isoforms in pancreatic cancer leads to unchecked KRAS-independent PI3K signaling, highlighting the need for therapeutic approaches targeting constitutive PI3K signaling.<\/jats:p>\n                    <jats:p>See related commentary by Tiriac and Engle, p. 1817<\/jats:p>\n                    <jats:p>See related article by Burge et al., p. 1868<\/jats:p>\n                    <jats:p>See related article by Kamgar et al., p. 2042<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-4501","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:30:41Z","timestamp":1761319841000},"page":"1854-1867","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-4333","authenticated-orcid":false,"given":"Rachel A.","family":"Burge","sequence":"first","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1126-8670","authenticated-orcid":false,"given":"Lucas","family":"Bialousow","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-9696","authenticated-orcid":false,"given":"Amanda J.","family":"Linke","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-3180","authenticated-orcid":false,"given":"Hannah S.","family":"Coalson","sequence":"additional","affiliation":[{"name":"2Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-4252","authenticated-orcid":false,"given":"Sara J.","family":"Adair","sequence":"additional","affiliation":[{"name":"3Department of Surgery, University of Virginia, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5049-9767","authenticated-orcid":false,"given":"Kamala","family":"Sundararaj","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3298-2543","authenticated-orcid":false,"given":"Merissa","family":"Smith","sequence":"additional","affiliation":[{"name":"4College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3895-4270","authenticated-orcid":false,"given":"Cameron","family":"Bumbleburg","sequence":"additional","affiliation":[{"name":"4College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-1848","authenticated-orcid":false,"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[{"name":"3Department of Surgery, University of Virginia, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-0612","authenticated-orcid":false,"given":"David F.","family":"Kashatus","sequence":"additional","affiliation":[{"name":"2Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-9681","authenticated-orcid":false,"given":"G. Aaron","family":"Hobbs","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina."},{"name":"5Hollings Cancer Center, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"2026041503162596400_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026041503162596400_bib2","doi-asserted-by":"crossref","first-page":"a031435","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: the critical driver and therapeutic target for pancreatic cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026041503162596400_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","article-title":"The Ras superfamily at a glance","volume":"118","author":"Wennerberg","year":"2005","journal-title":"J Cell Sci"},{"key":"2026041503162596400_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2007.03.051","article-title":"Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice","volume":"129","author":"Gupta","year":"2007","journal-title":"Cell"},{"key":"2026041503162596400_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12964-022-00823-5","article-title":"Reconstruction and analysis of a large-scale binary Ras-effector signaling network","volume":"20","author":"Catozzi","year":"2022","journal-title":"Cell Commun Signal"},{"key":"2026041503162596400_bib6","doi-asserted-by":"crossref","first-page":"e75715","DOI":"10.7554\/eLife.75715","article-title":"Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis","volume":"11","author":"Le Roux","year":"2022","journal-title":"Elife"},{"key":"2026041503162596400_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41568-018-0076-6","article-title":"A model for RAS mutation patterns in cancers: finding the sweet spot","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026041503162596400_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acr.2021.07.004","article-title":"Not all RAS mutations are equal: a detailed review of the functional diversity of RAS hot spot mutations","volume":"153","author":"Burge","year":"2022","journal-title":"Adv Cancer Res"},{"key":"2026041503162596400_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/2159-8290.CD-18-1220","article-title":"Tissue-specific oncogenic activity of KRASA146T","volume":"9","author":"Poulin","year":"2019","journal-title":"Cancer Discov"},{"key":"2026041503162596400_bib10","doi-asserted-by":"crossref","first-page":"eaaw8288","DOI":"10.1126\/scisignal.aaw8288","article-title":"A systems mechanism for KRAS mutant allele-specific responses to targeted therapy","volume":"12","author":"McFall","year":"2019","journal-title":"Sci Signal"},{"key":"2026041503162596400_bib11","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1073\/pnas.1908353116","article-title":"KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis","volume":"116","author":"Rabara","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503162596400_bib12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1158\/2159-8290.CD-20-0442","article-title":"An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants","volume":"10","author":"Zafra","year":"2020","journal-title":"Cancer Discov"},{"key":"2026041503162596400_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/2159-8290.CD-19-1006","article-title":"Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer","volume":"10","author":"Hobbs","year":"2020","journal-title":"Cancer Discov"},{"key":"2026041503162596400_bib14","doi-asserted-by":"crossref","first-page":"16692","DOI":"10.1073\/pnas.0608127103","article-title":"A Ras-induced conformational switch in the Ras activator Son of sevenless","volume":"103","author":"Freedman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503162596400_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","article-title":"BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition","volume":"11","author":"Hofmann","year":"2021","journal-title":"Cancer Discov"},{"key":"2026041503162596400_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/pancan.2021.0006","article-title":"Cobimetinib plus gemcitabine: an active combination in KRAS G12R-Mutated pancreatic ductal adenocarcinoma patients in previously treated and failed multiple chemotherapies","volume":"7","author":"Ardalan","year":"2021","journal-title":"J Pancreat Cancer"},{"key":"2026041503162596400_bib17","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ccell.2024.08.002","article-title":"Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer","volume":"42","author":"McIntyre","year":"2024","journal-title":"Cancer Cell"},{"key":"2026041503162596400_bib18","doi-asserted-by":"crossref","first-page":"eadk0775","DOI":"10.1126\/science.adk0775","article-title":"Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2026041503162596400_bib19","doi-asserted-by":"crossref","first-page":"eadk0850","DOI":"10.1126\/science.adk0850","article-title":"Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"2026041503162596400_bib20","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1172\/JCI74134","article-title":"RAS interaction with PI3K p110\u03b1 is required for tumor-induced angiogenesis","volume":"124","author":"Murillo","year":"2014","journal-title":"J Clin Invest"},{"key":"2026041503162596400_bib21","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.celrep.2018.12.003","article-title":"Disruption of the interaction of RAS with PI 3-kinase induces regression of EGFR-mutant-driven lung cancer","volume":"25","author":"Murillo","year":"2018","journal-title":"Cell Rep"},{"key":"2026041503162596400_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccr.2013.09.012","article-title":"Requirement for interaction of PI3-kinase p110\u03b1 with RAS in lung tumor maintenance","volume":"24","author":"Castellano","year":"2013","journal-title":"Cancer Cell"},{"key":"2026041503162596400_bib23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1053\/j.gastro.2014.08.032","article-title":"PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"2026041503162596400_bib24","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1101\/gad.249409.114","article-title":"Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110\u03b1","volume":"28","author":"Baer","year":"2014","journal-title":"Genes Dev"},{"key":"2026041503162596400_bib25","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/1535-7163.MCT-20-0981","article-title":"Phosphoproteomics identifies PI3K inhibitor-selective adaptive responses in pancreatic cancer cell therapy and resistance","volume":"20","author":"Cintas","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2026041503162596400_bib26","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"2026041503162596400_bib27","first-page":"220","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council (U.S.). Committee for the update of the guide for the care and use of laboratory animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.)","year":"2011","edition":"8th ed."},{"key":"2026041503162596400_bib28","doi-asserted-by":"crossref","first-page":"e77065","DOI":"10.1371\/journal.pone.0077065","article-title":"Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens","volume":"8","author":"Walters","year":"2013","journal-title":"PLoS One"},{"key":"2026041503162596400_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-17-2283","article-title":"CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer","volume":"24","author":"Michaels","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026041503162596400_bib30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1245\/s10434-016-5116-4","article-title":"Adjuvant trametinib delays the outgrowth of occult pancreatic cancer in a mouse model of patient-derived liver metastasis","volume":"23","author":"Newhook","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026041503162596400_bib31","doi-asserted-by":"crossref","first-page":"20336","DOI":"10.1074\/jbc.M111899200","article-title":"Reversible inactivation of the tumor suppressor PTEN by H2O2","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"2026041503162596400_bib32","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.96.5.2110","article-title":"Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"96","author":"Ramaswamy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503162596400_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nprot.2014.004","article-title":"Determining the macropinocytic index of cells through a quantitative image-based assay","volume":"9","author":"Commisso","year":"2014","journal-title":"Nat Protoc"},{"key":"2026041503162596400_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00109-015-1352-5","article-title":"Molecules in medicine mini-review: isoforms of PI3K in biology and disease","volume":"94","author":"Vanhaesebroeck","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"2026041503162596400_bib35","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/jm800295d","article-title":"The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer","volume":"51","author":"Folkes","year":"2008","journal-title":"J Med Chem"},{"key":"2026041503162596400_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/cc.8.4.7659","article-title":"Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy","volume":"8","author":"Choo","year":"2009","journal-title":"Cell Cycle"},{"key":"2026041503162596400_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"2026041503162596400_bib38","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1038\/sj.onc.1207902","article-title":"The PI 3-kinase\/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells","volume":"23","author":"Asano","year":"2004","journal-title":"Oncogene"},{"key":"2026041503162596400_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jcb.10287","article-title":"Frequent activation of AKT2 kinase in human pancreatic carcinomas","volume":"87","author":"Altomare","year":"2002","journal-title":"J Cell Biochem"},{"key":"2026041503162596400_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/antiox10020302","article-title":"Redox regulation of PTEN by peroxiredoxins","volume":"10","author":"Nguyen Huu","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2026041503162596400_bib41","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1002\/anie.201506338","article-title":"Redox modulation of PTEN phosphatase activity by hydrogen peroxide and bisperoxidovanadium complexes","volume":"54","author":"Lee","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"2026041503162596400_bib42","doi-asserted-by":"crossref","first-page":"101553","DOI":"10.1016\/j.redox.2020.101553","article-title":"Redox regulation of tumor suppressor PTEN in cell signaling","volume":"34","author":"Zhang","year":"2020","journal-title":"Redox Biol"},{"key":"2026041503162596400_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2020.09.043","article-title":"Rac1 and EGFR cooperate to activate Pak in response to nutrient stress","volume":"533","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"2026041503162596400_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.trecan.2019.04.002","article-title":"Macropinocytosis in cancer: a complex signaling network","volume":"5","author":"Zhang","year":"2019","journal-title":"Trends Cancer"},{"key":"2026041503162596400_bib45","doi-asserted-by":"crossref","first-page":"20180158","DOI":"10.1098\/rstb.2018.0158","article-title":"The origins and evolution of macropinocytosis","volume":"374","author":"King","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2026041503162596400_bib46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"2026041503162596400_bib47","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0119","article-title":"Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"2026041503162596400_bib48","doi-asserted-by":"crossref","first-page":"15044","DOI":"10.1038\/cddiscovery.2015.44","article-title":"The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells","volume":"1","author":"Wan","year":"2015","journal-title":"Cell Death Discov"},{"key":"2026041503162596400_bib49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oncolo\/oyac179","article-title":"KRAS mutation variants and co-occurring PI3K pathway alterations impact survival for patients with pancreatic ductal adenocarcinomas","volume":"27","author":"Diehl","year":"2022","journal-title":"Oncologist"},{"key":"2026041503162596400_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjc.6600031","article-title":"Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1","volume":"86","author":"Ebert","year":"2002","journal-title":"Br J Cancer"},{"key":"2026041503162596400_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: multiple functions in human malignant tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front Oncol"},{"key":"2026041503162596400_bib52","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1073\/pnas.0912524107","article-title":"Allele-specific tumor spectrum in pten knockin mice","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503162596400_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/0008-5472.CAN-23-1730","article-title":"PTEN lipid phosphatase activity suppresses melanoma formation by opposing an AKT\/mTOR\/FRA1 signaling axis","volume":"84","author":"Xu","year":"2024","journal-title":"Cancer Res"},{"key":"2026041503162596400_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccr.2005.07.015","article-title":"Pten constrains centroacinar cell expansion and malignant transformation in the pancreas","volume":"8","author":"Stanger","year":"2005","journal-title":"Cancer Cell"},{"key":"2026041503162596400_bib55","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1093\/emboj\/cdg513","article-title":"Redox regulation of PI 3-kinase signalling via inactivation of PTEN","volume":"22","author":"Leslie","year":"2003","journal-title":"EMBO J"},{"key":"2026041503162596400_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","article-title":"Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein","volume":"75","author":"Kamphorst","year":"2015","journal-title":"Cancer Res"},{"key":"2026041503162596400_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"key":"2026041503162596400_bib58","doi-asserted-by":"crossref","first-page":"e44235","DOI":"10.7554\/eLife.44235","article-title":"Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability","volume":"8","author":"Sullivan","year":"2019","journal-title":"Elife"},{"key":"2026041503162596400_bib59","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1038\/s41586-024-08084-7","article-title":"Author correction: tumour-selective activity of RAS-GTP inhibition in pancreatic cancer","volume":"635","author":"Wasko","year":"2024","journal-title":"Nature"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-4501\/3664915\/can-24-4501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/8\/1854\/3764871\/can-24-4501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/8\/1854\/3764871\/can-24-4501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:16:47Z","timestamp":1776237407000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/8\/1854\/782623\/PTEN-Oxidation-Promotes-Constitutive-PI3K"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,10,24]]},"published-print":{"date-parts":[[2026,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-4501","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.32711479","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711491","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711473","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711482","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711488","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711476","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32711485","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8542531","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}